These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 3171038

  • 21. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC, Meunier P, Terrier M, David L, Vignon G.
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [Abstract] [Full Text] [Related]

  • 22. Effects of synthetic salmon calcitonin in patients with Paget's disease of bone.
    Hamilton CR.
    Am J Med; 1974 Mar; 56(3):315-22. PubMed ID: 4855941
    [No Abstract] [Full Text] [Related]

  • 23. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease.
    Levy F, Muff R, Dotti-Sigrist S, Dambacher MA, Fischer JA.
    J Clin Endocrinol Metab; 1988 Sep; 67(3):541-5. PubMed ID: 3410939
    [Abstract] [Full Text] [Related]

  • 24. Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
    Reginster JY, Gennari C, Mautalen C, Deroisy R, Denis D, Lecart MP, Vandalem JL, Collette J, Franchimont P.
    Scand J Rheumatol; 1990 Sep; 19(1):83-6. PubMed ID: 2309107
    [No Abstract] [Full Text] [Related]

  • 25. Clinical efficacy of salmon calcitonin in Paget's disease of bone.
    Singer FR.
    Calcif Tissue Int; 1991 Sep; 49 Suppl 2():S7-8. PubMed ID: 1933617
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the acute biological action of injectable salmon calcitonin and an injectable and oral calcitonin analogue.
    Devogelaer JP, Azria M, Attinger M, Abbiati G, Castiglioni C, Nagant de Deuxchaisnes C.
    Calcif Tissue Int; 1994 Jul; 55(1):71-3. PubMed ID: 7922793
    [Abstract] [Full Text] [Related]

  • 27. [Hypocalcemia induced in patients with Paget's disease by nasal salmon calcitonin. Effects of anti-calcitonin salmine antibodies].
    Reginster JY, Almer S, Gaspar S, Albert A, Deroisy R, Franchimont P.
    Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):563-7. PubMed ID: 2756322
    [No Abstract] [Full Text] [Related]

  • 28. [Variations in parathormone serum levels during treatment of Paget's disease with calcitonin of human or salmon origin (author's transl)].
    Heynen G, Franchimont P, Gaspar S, Gysen P, Kanis JA.
    Ann Endocrinol (Paris); 1981 Jun; 42(3):265-75. PubMed ID: 7316460
    [Abstract] [Full Text] [Related]

  • 29. Paget's disease. Radiological changes occurring in untreated patients and those on therapy with salmon calcitonin during two years' observation.
    Woodhouse NJ, Chalmers AH, Wells IP, Dewbury KC, Mohamedally SM.
    Br J Radiol; 1977 Oct; 50(598):699-705. PubMed ID: 562693
    [Abstract] [Full Text] [Related]

  • 30. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S, Rosenberg E, Haddad JG.
    Lancet; 1974 Dec 14; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract] [Full Text] [Related]

  • 31. Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's disease.
    González D, Vega E, Ghiringhelli G, Mautalen C.
    Calcif Tissue Int; 1987 Dec 14; 41(6):313-5. PubMed ID: 3124939
    [Abstract] [Full Text] [Related]

  • 32. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC, Harrison JE, Wilson DR.
    Can Med Assoc J; 1977 Nov 05; 117(9):1031-4. PubMed ID: 562231
    [Abstract] [Full Text] [Related]

  • 33. Human calcitonin treatment of Paget's disease of bone.
    Singer FR.
    Clin Orthop Relat Res; 1977 Nov 05; (127):86-93. PubMed ID: 912995
    [Abstract] [Full Text] [Related]

  • 34. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
    Deplante JP, Daumont A, Bouvier M, Lejeune E.
    Nouv Presse Med; 1978 Nov 25; 7(41):3753-6. PubMed ID: 733525
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of drugs for Paget's disease of bone.
    Reginster JY, Lecart MP.
    Bone; 1995 Nov 25; 17(5 Suppl):485S-488S. PubMed ID: 8573423
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of Paget's disease with synthetic human calcitonin (author's transl)].
    Gerschpacher H, Schindler H.
    Wien Klin Wochenschr; 1980 Aug 01; 92(15):535-8. PubMed ID: 6933743
    [Abstract] [Full Text] [Related]

  • 37. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE.
    Arch Intern Med; 1989 Dec 01; 149(12):2765-7. PubMed ID: 2596945
    [Abstract] [Full Text] [Related]

  • 38. The effect of nasal hCT on bone turnover in Paget's disease of bone--implications for the treatment of other metabolic bone diseases.
    Reginster JY, Jeugmans-Huynen AM, Wouters M, Sarlet N, McIntyre HD, Franchimont P.
    Br J Rheumatol; 1992 Jan 01; 31(1):35-9. PubMed ID: 1730104
    [Abstract] [Full Text] [Related]

  • 39. Paget's disease of the skull and migraine headache.
    Hamilton CR, Quesada O.
    Johns Hopkins Med J; 1973 Mar 01; 132(3):179-85. PubMed ID: 4266199
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of Paget's disease of bone.
    Evans RA.
    Med J Aust; 1983 Feb 19; 1(4):159-62. PubMed ID: 6405139
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.